The potential growth difference for the carrier screening market from 2021 to 2026 is USD 2.36 billion. To get the exact yearly growth variance and the Y-O-Y growth rate, Talk to our analyst.
Key Market Dynamics:
- Market Driver
- The increased frequency of genetic illnesses and disorders such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia is one of the important reasons driving the worldwide carrier screening market growth. Prenatal testing has become more popular as the frequency of impairments in infants has increased, allowing doctors to swiftly treat treatable genetic abnormalities and diseases.
- According to the CDC, every year in the United States, one out of every 33 newborns (about 3%) is born with birth defects. Around the world, between 7 million and 9 million kids are born with birth disorders. Furthermore, parents with inheritable genetic illnesses such as autosomal dominant and recessive disorders prefer prenatal testing protocols for early disease detection.
- Market Challenges
- One of the significant carrier screening market trends that are projected to drive market expansion in the forecast period is the rising tendencies of next-generation sequencing (NGS) technology in carrier screening. NGS has advanced genetic research by allowing wide-scale sequencing of the human genome to find disease-causing mutations and gene variations of intermediate to large size.
To learn about additional key drivers, trends, and challenges available with Technavio. Read our FREE Sample Report right now!
The carrier screening market report is segmented by Type (Expanded carrier screening and Targeted disease carrier screening) and Geography (North America, Europe, Asia, and the Rest of the World (ROW)). North America will be the leading region with 37% of the market's growth during the forecast period. The US, Germany, UK, Japan, and China are the key market for carrier screening in North America. Growing concerns on early disease diagnosis, a significant rise in commercial approvals for advanced carrier screening, and the increasing use of pharmacogenomic testing will facilitate the carrier screening market growth in North America over the forecast period.
The expanded carrier screening sector will gain a substantial amount of market share. Advancements in the extended carrier screening market, such as Sema4 Elements Expanded Carrier Screen (ECS) with Personalized Residual Risk solution from Sema4 OpCo, Inc, are likely to boost demand, resulting in segment growth throughout the projection period.
View our sample report for additional insights into the contribution of all the segments, and regional opportunities in the report.
Some Companies Mentioned with their Offerings
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
- Abbott Laboratories
- Agilent Technologies Inc.
- CENTOGENE NV
- Danaher Corp.
- Eurofins Scientific SE
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- Fulgent Genetics
- Gene By Gene Ltd
- Illumina Inc.
- Invitae Corp.
- Laboratory Corp. of America Holdings
- MedGenome Labs Ltd.
- Myriad Genetics Inc.
- Natera Inc.
- OPKO Health Inc.
To gain access to more vendor profiles with their key offerings available with Technavio, Click Here
Related Reports:
3D Cell Culture Market: The 3D cell culture market share is expected to increase by USD 1.28 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 15.69%. Download our free Sample Report.
Blood Grouping Reagents Market: The blood-grouping reagents market share is expected to increase by USD 485.33 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.19%.Download our free Sample Report.
Carrier Screening Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 17.66% |
Market growth 2022-2026 |
$ 2.36 billion |
Market structure |
Fragmented |
YoY growth (%) |
16.91 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Germany, UK, Japan, and China |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., Eurofins Scientific SE, DiaSorin SpA, F. Hoffmann La Roche Ltd., Fulgent Genetics, Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Expanded carrier screening - Market size and forecast 2021-2026
- Exhibit 28: Chart on Expanded carrier screening - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Expanded carrier screening - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Expanded carrier screening - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Expanded carrier screening - Year-over-year growth 2021-2026 (%)
- 5.4 Targeted disease carrier screening - Market size and forecast 2021-2026
- Exhibit 32: Chart on Targeted disease carrier screening - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Targeted disease carrier screening - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Targeted disease carrier screening - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Targeted disease carrier screening - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Type
- Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 Japan - Market size and forecast 2021-2026
- Exhibit 66: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.10 UK - Market size and forecast 2021-2026
- Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.11 China - Market size and forecast 2021-2026
- Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 Abbott Laboratories
- Exhibit 85: Abbott Laboratories - Overview
- Exhibit 86: Abbott Laboratories - Business segments
- Exhibit 87: Abbott Laboratories - Key news
- Exhibit 88: Abbott Laboratories - Key offerings
- Exhibit 89: Abbott Laboratories - Segment focus
- 10.4 Danaher Corp.
- Exhibit 90: Danaher Corp. - Overview
- Exhibit 91: Danaher Corp. - Business segments
- Exhibit 92: Danaher Corp. - Key news
- Exhibit 93: Danaher Corp. - Key offerings
- Exhibit 94: Danaher Corp. - Segment focus
- 10.5 Eurofins Scientific SE
- Exhibit 95: Eurofins Scientific SE - Overview
- Exhibit 96: Eurofins Scientific SE - Business segments
- Exhibit 97: Eurofins Scientific SE - Key news
- Exhibit 98: Eurofins Scientific SE - Key offerings
- Exhibit 99: Eurofins Scientific SE - Segment focus
- 10.6 F. Hoffmann La Roche Ltd.
- Exhibit 100: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 101: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 102: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 103: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 104: F. Hoffmann La Roche Ltd. - Segment focus
- 10.7 Fulgent Genetics
- Exhibit 105: Fulgent Genetics - Overview
- Exhibit 106: Fulgent Genetics - Business segments
- Exhibit 107: Fulgent Genetics - Key offerings
- Exhibit 108: Fulgent Genetics - Segment focus
- 10.8 Illumina Inc.
- Exhibit 109: Illumina Inc. - Overview
- Exhibit 110: Illumina Inc. - Product / Service
- Exhibit 111: Illumina Inc. - Key offerings
- 10.9 Invitae Corp.
- Exhibit 112: Invitae Corp. - Overview
- Exhibit 113: Invitae Corp. - Product / Service
- Exhibit 114: Invitae Corp. - Key offerings
- 10.10 OPKO Health Inc.
- Exhibit 115: OPKO Health Inc. - Overview
- Exhibit 116: OPKO Health Inc. - Business segments
- Exhibit 117: OPKO Health Inc. - Key news
- Exhibit 118: OPKO Health Inc. - Key offerings
- Exhibit 119: OPKO Health Inc. - Segment focus
- 10.11 Quest Diagnostics Inc.
- Exhibit 120: Quest Diagnostics Inc. - Overview
- Exhibit 121: Quest Diagnostics Inc. - Business segments
- Exhibit 122: Quest Diagnostics Inc. - Key offerings
- Exhibit 123: Quest Diagnostics Inc. - Segment focus
- 10.12 Thermo Fisher Scientific Inc.
- Exhibit 124: Thermo Fisher Scientific Inc. - Overview
- Exhibit 125: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 126: Thermo Fisher Scientific Inc. - Key news
- Exhibit 127: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 128: Thermo Fisher Scientific Inc. - Segment focus
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 129: Inclusions checklist
- Exhibit 130: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 131: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 132: Research methodology
- Exhibit 133: Validation techniques employed for market sizing
- Exhibit 134: Information sources
- 11.5 List of abbreviations
- Exhibit 135: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article